EW insider transaction filings
Edwards Lifesciences Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-14. Screen EW transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 17 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 11 filings by 6 insiders — 51,399 shares, $4,596,451 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 30,646 shares @ $90.99 ($2,788,547) by Chopra Daveen, filed 2026-08-26.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Chopra Daveen — CVP, TMTT, Surgical & IHFM | 2 | — | 2 legs · 31,800 sh · $2,894,440 | 3 |
| Markowitz Wayne — CVP, JAPAC | 4 | — | 3 legs · 11,014 sh · $944,962 | 4 |
| Zovighian Bernard J — CEO, Director | 1 | — | 1 leg · 2,921 sh · $245,134 | 2 |
| Bruls Annette — CVP, EMEACLA | 2 | — | 1 leg · 2,644 sh · $237,907 | 1 |
| Lippis Daniel J. — CVP, TAVR | 5 | — | 4 legs · 2,476 sh · $224,474 | 9 |
| Dahl Andrew M. — SVP, Corporate Controller | 2 | — | 1 leg · 544 sh · $49,534 | 1 |
| Mistras Theodora — CVP, Chief Financial Officer | 1 | — | — | 4 |
Recent Form 4 filings — Edwards Lifesciences Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | Dahl Andrew M. — SVP, Corporate Controller | Tax withholding (F): 253 @ $84.37 | EDGAR |
| 2026-09-14 | 4 | Markowitz Wayne — CVP, JAPAC | Tax withholding (F): 355 @ $86.77 · Tax withholding (F): 568 @ $84.37 | EDGAR |
| 2026-09-11 | 4 | Lippis Daniel J. — CVP, TAVR | Option exercise (M): 619 @ $72.68 · Sale (S): 619 @ $87.51 · Option exercise (M): 619 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Chopra Daveen — CVP, TMTT, Surgical & IHFM | Tax withholding (F): 398 @ $86.77 | EDGAR |
| 2026-08-31 | 4 | Dahl Andrew M. — SVP, Corporate Controller | Sale (S): 544 @ $91.06 | EDGAR |
| 2026-08-28 | 4 | Bruls Annette — CVP, EMEACLA | Sale (S): 2,644 @ $89.98 | EDGAR |
| 2026-08-26 | 4 | Chopra Daveen — CVP, TMTT, Surgical & IHFM | Option exercise (M): 31,800 @ $72.68 · Sale (S): 1,154 @ $91.76 · Sale (S): 30,646 @ $90.99 · Option exercise (M): 31,800 (derivative) @ $0 | EDGAR |
| 2026-08-26 | 4 | Markowitz Wayne — CVP, JAPAC | Sale (S): 1,240 @ $91.47 | EDGAR |
| 2026-08-11 | 4 | Lippis Daniel J. — CVP, TAVR | Option exercise (M): 619 @ $72.68 · Sale (S): 619 @ $92.03 · Option exercise (M): 619 (derivative) @ $0 | EDGAR |
| 2026-07-30 | 4 | Markowitz Wayne — CVP, JAPAC | Sale (S): 146.31 @ $86.03 | EDGAR |
| 2026-07-28 | 4 | Markowitz Wayne — CVP, JAPAC | Option exercise (M): 9,628 @ $74.02 · Sale (S): 9,628 @ $85.06 · Option exercise (M): 9,628 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Zovighian Bernard J — CEO, Director | Gift (G): 319.65 @ $0 · Gift (G): 319.65 @ $0 · Sale (S): 2,920.55 @ $83.93 | EDGAR |
| 2026-07-13 | 4 | Bruls Annette — CVP, EMEACLA | Tax withholding (F): 109 @ $92.21 | EDGAR |
| 2026-07-10 | 4 | Mistras Theodora — CVP, Chief Financial Officer | Grant/award (A): 87,595 @ $0 · Grant/award (A): 12,325 @ $0 · Grant/award (A): 61,800 (derivative) @ $0 · Grant/award (A): 12,325 (derivative) @ $0 | EDGAR |
| 2026-07-10 | 4 | Lippis Daniel J. — CVP, TAVR | Option exercise (M): 619 @ $72.68 · Sale (S): 619 @ $91.70 · Option exercise (M): 619 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Lippis Daniel J. — CVP, TAVR | Tax withholding (F): 377 @ $95.18 | EDGAR |
| 2026-06-30 | 4 | Lippis Daniel J. — CVP, TAVR | Option exercise (M): 619 @ $72.68 · Sale (S): 619 @ $91.40 · Option exercise (M): 619 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Zovighian Bernard J — CEO, Director | Sale (S): 523 @ $87.92 | EDGAR |
| 2026-05-29 | 4 | Dahl Andrew M. — SVP, Corporate Controller | Sale (S): 567.53 @ $86.08 | EDGAR |
| 2026-05-27 | 4 | BOBO DONALD E JR — CVP,Strategy/Corp Development | Sale (S): 23,145 @ $86.42 | EDGAR |
| 2026-05-22 | 4 | Chopra Daveen — CVP, TMTT & Surgical | Sale (S): 1,500 @ $84.60 | EDGAR |
| 2026-05-18 | 4 | Lippis Daniel J. — CVP, TAVR | Option exercise (M): 620 @ $72.68 · Sale (S): 620 @ $81.14 · Option exercise (M): 620 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | BOBO DONALD E JR — CVP,Strategy/Corp Development | Sale (S): 9,968 @ $82.07 · Sale (S): 8,000 @ $81.82 | EDGAR |
| 2026-05-12 | 4 | Zovighian Bernard J — CEO, Director | Option exercise (M): 47,207 @ $0 · Tax withholding (F): 26,198 @ $79.96 · Gift (G): 26,640 @ $0 · Gift (G): 26,640 @ $0 · Sale (S): 845 @ $78.40 · Sale (S): 35,506 @ $77.92 · +1 more | EDGAR |
| 2026-05-12 | 4 | BOBO DONALD E JR — CVP,Strategy/Corp Development | Option exercise (M): 13,457 @ $0 · Tax withholding (F): 7,469 @ $79.96 · Option exercise (M): 13,457 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Chopra Daveen — CVP, TMTT & Surgical | Option exercise (M): 13,583 @ $0 · Tax withholding (F): 7,538 @ $79.96 · Option exercise (M): 13,583 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Ullem Scott B. — CVP, Chief Financial Officer | Option exercise (M): 19,830 @ $0 · Tax withholding (F): 11,004 @ $79.96 · Option exercise (M): 19,830 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Markowitz Wayne — CVP, JAPAC | Grant/award (A): 5,200 @ $0 · Tax withholding (F): 264 @ $83.20 · Tax withholding (F): 226 @ $82.76 · Sale (S): 593 @ $79.73 · Grant/award (A): 26,400 (derivative) @ $0 · Grant/award (A): 5,200 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Zovighian Bernard J — CEO, Director | Grant/award (A): 43,800 @ $0 · Tax withholding (F): 4,153 @ $83.20 · Gift (G): 4,222 @ $0 · Tax withholding (F): 5,398 @ $82.76 · Gift (G): 5,489 @ $0 · Gift (G): 4,222 @ $0 · +3 more | EDGAR |
| 2026-05-11 | 4 | Lippis Daniel J. — CVP, TAVR | Tax withholding (F): 362 @ $79.96 | EDGAR |
| 2026-05-08 | 4 | VALERIANI NICHOLAS J — Director | Grant/award (A): 5,127 @ $0 | EDGAR |
| 2026-05-08 | 4 | Sequeira Ramona — Director | Grant/award (A): 3,251 @ $0 | EDGAR |
| 2026-05-08 | 4 | LORANGER STEVEN R — Director | Grant/award (A): 3,251 @ $0 · Grant/award (A): 1,064 @ $0 | EDGAR |
| 2026-05-08 | 4 | LAVIOLETTE PAUL A — Director | Grant/award (A): 3,251 @ $0 | EDGAR |
| 2026-05-08 | 4 | STONE HEISZ LESLIE — Director | Grant/award (A): 3,251 @ $0 | EDGAR |
| 2026-05-08 | 4 | GALLAHUE KIERAN — Director | Grant/award (A): 3,251 @ $0 · Grant/award (A): 1,064 @ $0 | EDGAR |
| 2026-05-08 | 4 | Feinberg David T — Director | Grant/award (A): 3,251 @ $0 | EDGAR |
| 2026-05-08 | 4 | BOBO DONALD E JR — CVP,Strategy/Corp Development | Grant/award (A): 7,850 @ $0 · Tax withholding (F): 831 @ $83.20 · Tax withholding (F): 1,038 @ $82.76 · Grant/award (A): 44,000 (derivative) @ $0 · Grant/award (A): 7,850 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Ullem Scott B. — CVP, Chief Financial Officer | Tax withholding (F): 1,373 @ $83.20 · Tax withholding (F): 1,661 @ $82.76 | EDGAR |
| 2026-05-08 | 4 | Davis Leslie C. — Director | Grant/award (A): 3,251 @ $0 | EDGAR |
| 2026-05-08 | 4 | Lippis Daniel J. — CVP, TAVR | Grant/award (A): 7,850 @ $0 · Tax withholding (F): 309 @ $83.20 · Tax withholding (F): 450 @ $82.76 · Grant/award (A): 39,900 (derivative) @ $0 · Grant/award (A): 7,850 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Dahl Andrew M. — SVP, Corporate Controller | Grant/award (A): 3,985 @ $0 · Grant/award (A): 3,020 @ $0 · Tax withholding (F): 289 @ $82.76 · Grant/award (A): 6,745 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Chopra Daveen — CVP, TMTT & Surgical | Grant/award (A): 9,675 @ $0 · Tax withholding (F): 674 @ $83.20 · Tax withholding (F): 1,141 @ $82.76 · Grant/award (A): 49,100 (derivative) @ $0 · Grant/award (A): 9,675 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Bruls Annette — CVP, EMEACLA | Grant/award (A): 6,650 @ $0 · Tax withholding (F): 84 @ $82.76 · Grant/award (A): 33,700 (derivative) @ $0 · Grant/award (A): 6,650 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Ullem Scott B. — CVP, Chief Financial Officer | Tax withholding (F): 620 @ $83.98 · Option exercise (M): 13,000 @ $59.26 · Tax withholding (F): 11,131 @ $82.91 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Zovighian Bernard J — CEO, Director | Tax withholding (F): 515 @ $83.98 · Gift (G): 523 @ $0 · Gift (G): 523 @ $0 | EDGAR |
| 2026-05-04 | 4 | Lippis Daniel J. — CVP, TAVR | Option exercise (M): 1,019 @ $59.26 · Sale (S): 19 @ $83.99 · Sale (S): 1,000 @ $82.99 · Tax withholding (F): 252 @ $83.98 · Option exercise (M): 1,019 @ $59.26 · Sale (S): 1,019 @ $83.98 · +2 more | EDGAR |
| 2026-05-04 | 4 | Chopra Daveen — CVP, TMTT & Surgical | Tax withholding (F): 282 @ $83.98 | EDGAR |
| 2026-05-04 | 4 | BOBO DONALD E JR — CVP,Strategy/Corp Development | Tax withholding (F): 469 @ $83.98 | EDGAR |
| 2026-04-09 | 4 | Ullem Scott B. — CVP, Chief Financial Officer | Option exercise (M): 13,000 @ $59.26 · Sale (S): 4,676 @ $80.50 · Sale (S): 8,324 @ $79.79 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Edwards Lifesciences Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-04-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-19 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=EW returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →